Canadian ENHANCE data support the efficacy and safety of drotrecogin alfa (activated) despite higher disease severity than the global ENHANCE population

Detalles Bibliográficos
Autores principales: Hall, R, Fisher, H, Marshall, J, Hodder, R, Russell, J, Lee, B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098344/
http://dx.doi.org/10.1186/cc3257
_version_ 1782326316281888768
author Hall, R
Fisher, H
Marshall, J
Hodder, R
Russell, J
Lee, B
author_facet Hall, R
Fisher, H
Marshall, J
Hodder, R
Russell, J
Lee, B
author_sort Hall, R
collection PubMed
description
format Online
Article
Text
id pubmed-4098344
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40983442014-09-23 Canadian ENHANCE data support the efficacy and safety of drotrecogin alfa (activated) despite higher disease severity than the global ENHANCE population Hall, R Fisher, H Marshall, J Hodder, R Russell, J Lee, B Crit Care Poster Presentation BioMed Central 2005 2005-03-07 /pmc/articles/PMC4098344/ http://dx.doi.org/10.1186/cc3257 Text en Copyright © 2005 BioMed Central Ltd
spellingShingle Poster Presentation
Hall, R
Fisher, H
Marshall, J
Hodder, R
Russell, J
Lee, B
Canadian ENHANCE data support the efficacy and safety of drotrecogin alfa (activated) despite higher disease severity than the global ENHANCE population
title Canadian ENHANCE data support the efficacy and safety of drotrecogin alfa (activated) despite higher disease severity than the global ENHANCE population
title_full Canadian ENHANCE data support the efficacy and safety of drotrecogin alfa (activated) despite higher disease severity than the global ENHANCE population
title_fullStr Canadian ENHANCE data support the efficacy and safety of drotrecogin alfa (activated) despite higher disease severity than the global ENHANCE population
title_full_unstemmed Canadian ENHANCE data support the efficacy and safety of drotrecogin alfa (activated) despite higher disease severity than the global ENHANCE population
title_short Canadian ENHANCE data support the efficacy and safety of drotrecogin alfa (activated) despite higher disease severity than the global ENHANCE population
title_sort canadian enhance data support the efficacy and safety of drotrecogin alfa (activated) despite higher disease severity than the global enhance population
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098344/
http://dx.doi.org/10.1186/cc3257
work_keys_str_mv AT hallr canadianenhancedatasupporttheefficacyandsafetyofdrotrecoginalfaactivateddespitehigherdiseaseseveritythantheglobalenhancepopulation
AT fisherh canadianenhancedatasupporttheefficacyandsafetyofdrotrecoginalfaactivateddespitehigherdiseaseseveritythantheglobalenhancepopulation
AT marshallj canadianenhancedatasupporttheefficacyandsafetyofdrotrecoginalfaactivateddespitehigherdiseaseseveritythantheglobalenhancepopulation
AT hodderr canadianenhancedatasupporttheefficacyandsafetyofdrotrecoginalfaactivateddespitehigherdiseaseseveritythantheglobalenhancepopulation
AT russellj canadianenhancedatasupporttheefficacyandsafetyofdrotrecoginalfaactivateddespitehigherdiseaseseveritythantheglobalenhancepopulation
AT leeb canadianenhancedatasupporttheefficacyandsafetyofdrotrecoginalfaactivateddespitehigherdiseaseseveritythantheglobalenhancepopulation

Ejemplares similares